Kessler P D, Byrne B J
Peter Belfer Cardiac Laboratory, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Annu Rev Physiol. 1999;61:219-42. doi: 10.1146/annurev.physiol.61.1.219.
This review surveys a wide range of cellular and molecular approaches to strengthening the injured or weakened heart, focusing on strategies to replace dysfunctional, necrotic, or apoptotic cardiomyocytes with new cells of mesodermal origin. A variety of cell types, including myogenic cell lines, adult skeletal myoblasts, immoratalized atrial cells, embryonic and adult cardiomyocytes, embryonic stem cells, tetratoma cells, genetically altered fibroblasts, smooth muscle cells, and bone marrow-derived cells have all been proposed as useful cells in cardiac repair and may have the capacity to perform cardiac work. We focus on the implantation of mesodermally derived cells, the best developed of the options. We review the developmental and cell biology that have stimulated these studies, examine the limitations of current knowledge, and identify challenges for the future, which we believe are considerable.
本综述探讨了一系列用于强化受损或衰弱心脏的细胞和分子方法,重点关注用中胚层来源的新细胞替代功能失调、坏死或凋亡的心肌细胞的策略。多种细胞类型,包括肌源性细胞系、成年骨骼肌成肌细胞、永生化心房细胞、胚胎和成体心肌细胞、胚胎干细胞、畸胎瘤细胞、基因改造的成纤维细胞、平滑肌细胞以及骨髓来源的细胞,均被提议作为心脏修复中的有用细胞,并且可能具备执行心脏功能的能力。我们重点关注中胚层来源细胞的植入,这是目前已充分发展的选择。我们回顾了推动这些研究的发育生物学和细胞生物学,审视了当前知识的局限性,并确定了未来面临的挑战,我们认为这些挑战颇为严峻。